scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to scPharmaceuticals Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Scpharmaceuticals Inc. (SCPH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 4,096,367 | $10,773,445 | -2% | 4.46% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.00 | 21,658 | Large Shareholder | 252,858 | 2024-08-13 | Filing | |
| $4.00 | 478,342 | Large Shareholder | 5,806,670 | 2024-08-13 | Filing | |
| $5.25 | 762,380 | Large Shareholder | 5,328,328 | 2022-11-25 | Filing | |
| $3.91 | 5,000 | Director | 5,000 | 2021-12-03 | Filing | |
| $3.96 | 10,000 | Officer, Director | 46,962 | 2021-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.09 | 87,036 | Large Shareholder | 410,268 | 2022-10-10 | Filing | |
| $4.09 | 19,017 | Large Shareholder | 92,983 | 2022-10-10 | Filing | |
| $4.09 | 456,413 | Large Shareholder | 2,231,601 | 2022-10-10 | Filing | |
| $5.02 | 5,808 | Large Shareholder | 497,304 | 2022-10-06 | Filing | |
| $5.02 | 1,269 | Large Shareholder | 112,000 | 2022-10-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,356,812 | $6,198,417 | 0% | |
| 2. | 1,992,760 | $5,240,959 | 0% | |
| 3. | 1,398,057 | $3,676,890 | 0.22% | |
| 4. | 120,897 | $317,959 | 0% | |
| 5. | 105,935 | $278,609 | 0% |
News See All
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to scPharmaceuticals' Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals Second Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the scPharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.48.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to the scPharmaceuticals Third Quarter 2023 Earnings Conference Call.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2023 Earnings Call Transcript
Operator: Good day and welcome to the scPharmaceuticals Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2022 Earnings Call Transcript
PJ Kelleher: Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals Third Quarter 2022 Earnings Call. As a reminder, this conference is being recorded.
Billionaire Hedge Funds
